Back to Screener

Healthcare

Astellas Pharma Inc.(ALPMY)

Live Price

Offline

$13.34

+1.44% today

1Y Change

+37.68%

Window

Jun 27, 2025 โ†’ Jun 17, 2026

Market Cap
$3.95T
Revenue Growth
+18.6%
EPS Growth
+508.7%
Dividend Yield
3.5%

Coverage: 245 bars ยท Jun 27, 2025 โ†’ Jun 17, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Astellas Pharma Inc. (ALPMY) is a Healthcare stock with a market cap of $3.95T. The stock last traded around $13.34 and up 37.7% across the available one-year price window (Jun 27, 2025 โ†’ Jun 17, 2026). Baseline metrics include revenue growth of +18.6%, EPS growth of +508.7%, a dividend yield of 3.5%. What stands out right now is revenue +18.6%, EPS +508.7%, free cash flow +293.1% with operating margin 18.9% and ROIC 12.1%. The dividend matters to the case here, with a current yield around 3.5%. Valuation is more restrained than many high-expectation growth names at P/E 13.6 and price/sales 1.8. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines ALPMY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

ALPMY vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

ALPMY

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

ALPMY Max Drawdown

-21.28%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for ALPMY and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedApr 24, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
Apr 24, 26
โ€”
Est 0.18
โ€”
โ€”
Est 3298140.0B
โ€”
Apr 24
โ€”
Feb 4, 26
โœ“
0.36
Est 0.29
+24.8%
3642315.0B
Est 3383676.0B
+7.6%
Feb 4
โ€”
Oct 30, 25
โœ“
0.30
Est 0.20
+50.5%
3555432.2B
Est 3421520.2B
+3.9%
Oct 30
โ€”
Jul 30, 25
โœ“
0.40
Est 0.14
+195.0%
3492664.4B
Est 3235411.4B
+8.0%
Jul 30
โ€”
Apr 25, 25
โœ“
0.27
Est 0.15
+84.3%
3158114.7B
Est 3162403.0B
-0.1%
Apr 25
โ€”
Feb 4, 25
โœ“
0.30
Est 0.16
+89.9%
3290714.9B
Est 2908587.8B
+13.1%
Feb 4
โ€”
Oct 30, 24
โœ“
0.13
Est 0.12
+7.5%
3110019.5B
Est 2958849.2B
+5.1%
Oct 30
โ€”
Aug 1, 24
โœ“
0.24
Est 0.06
+300.0%
2945670.0B
Est 2604007.1B
+13.1%
Aug 1
โ€”
Apr 25, 24
โœ“
0.11
Est -0.02
+677.4%
2733056.4B
Est 2489880.1B
+9.8%
Apr 25
โ€”
Feb 5, 24
โœ“
0.12
Est 0.11
+5.6%
3016090.5B
Est 2554917.5B
+18.1%
Feb 5
โ€”
Nov 1, 23
โœ—
-0.01
Est 0.17
-105.9%
2624117.0B
Est 2364502.6B
+11.0%
Nov 1
โ€”
Aug 1, 23
โœ—
0.13
Est 0.22
-40.1%
2594743.3B
Est 2628790.4B
-1.3%
Aug 1
โ€”
Apr 27, 23
โœ“
0.15
Est -0.16
+196.4%
2673554.9B
Est 2698291.4B
-0.9%
Apr 27
โ€”
Feb 6, 23
โœ—
0.27
Est 0.29
-8.0%
3100539.7B
Est 2865343.7B
+8.2%
Feb 6
โ€”
Oct 31, 22
โœ“
0.28
Est 0.22
+24.5%
2630804.9B
Est 2526934.2B
+4.1%
Oct 31
โ€”
Aug 1, 22
โœ—
0.10
Est 0.16
-36.4%
2808900.0B
Est 2614227.5B
+7.5%
Aug 1
โ€”
Apr 27, 22
โœ—
-0.04
Est 0.18
-122.6%
2485048.9B
Est 2671393.5B
-7.0%
Apr 27
โ€”
Feb 2, 22
โœ“
0.34
Est 0.30
+15.0%
2961479.3B
Est 3058495.0B
-3.2%
Feb 2
โ€”
Oct 29, 21
0.20
Est โ€”
โ€”
2922437.0B
Est โ€”
โ€”
Oct 29
โ€”
Jul 30, 21
0.15
Est โ€”
โ€”
2934526.0B
Est โ€”
โ€”
Jul 30
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the market calendar